Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Cowart

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The Annals of Pharmacotherapy|November 21, 2019
Oral Semaglutide: First-in-Class Oral GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes MellitusKevin Cowart
American Journal of Pharmaceutical Education|June 21, 2017
Response to a Plea for Psychometric RigorKevin Cowart
Clinical Diabetes : a Publication of the American Diabetes Association|July 24, 2020
Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal InsulinKevin Cowart
Journal of Managed Care & Specialty Pharmacy|July 28, 2020
Flash Continuous Glucose Monitoring in Primary Care Settings: The Need for Measurement of Novel Glycemic Metrics to Adopt Policy and Practice ChangeKevin Cowart
Journal of Diabetes Science and Technology|December 14, 2019
A Review of the First Long-term Implantable Continuous Glucose Monitoring System Available in the United StatesKevin Cowart
Clinical Diabetes : a Publication of the American Diabetes Association|August 23, 2021
Expanding Flash Continuous Glucose Monitoring Technology to a Broader PopulationKevin Cowart
Journal of Pharmacy Practice|March 18, 2021
Flash Continuous Glucose Monitoring: A Practical Guide and Call to Action for PharmacistsKevin Cowart, Janice Zgibor
Journal of the American Pharmacists Association : Japha|December 22, 2018
Impact of pharmacist care provision in value-based care settings: How are we measuring value-added services?Kevin Cowart, Kevin Olson
Journal of Pharmacy Practice|May 18, 2018
Pharmacist Impact on Treatment Intensification and Hemoglobin A<sub>1C</sub> in Patients With Type 2 Diabetes Mellitus at an Academic Health CenterKevin Cowart, Karen Sando
Diabetes, Obesity & Metabolism|June 11, 2025
Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed-ratio basal insulin glucagon-like peptide-1 receptor agonist combinations?Kevin Cowart, Nicholas W Carris
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The Annals of Pharmacotherapy|November 21, 2019
Oral Semaglutide: First-in-Class Oral GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes MellitusKevin Cowart
American Journal of Pharmaceutical Education|June 21, 2017
Response to a Plea for Psychometric RigorKevin Cowart
Clinical Diabetes : a Publication of the American Diabetes Association|July 24, 2020
Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal InsulinKevin Cowart
Journal of Managed Care & Specialty Pharmacy|July 28, 2020
Flash Continuous Glucose Monitoring in Primary Care Settings: The Need for Measurement of Novel Glycemic Metrics to Adopt Policy and Practice ChangeKevin Cowart
Journal of Diabetes Science and Technology|December 14, 2019
A Review of the First Long-term Implantable Continuous Glucose Monitoring System Available in the United StatesKevin Cowart
Clinical Diabetes : a Publication of the American Diabetes Association|August 23, 2021
Expanding Flash Continuous Glucose Monitoring Technology to a Broader PopulationKevin Cowart
Journal of Pharmacy Practice|March 18, 2021
Flash Continuous Glucose Monitoring: A Practical Guide and Call to Action for PharmacistsKevin Cowart, Janice Zgibor
Journal of the American Pharmacists Association : Japha|December 22, 2018
Impact of pharmacist care provision in value-based care settings: How are we measuring value-added services?Kevin Cowart, Kevin Olson
Journal of Pharmacy Practice|May 18, 2018
Pharmacist Impact on Treatment Intensification and Hemoglobin A<sub>1C</sub> in Patients With Type 2 Diabetes Mellitus at an Academic Health CenterKevin Cowart, Karen Sando
Diabetes, Obesity & Metabolism|June 11, 2025
Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed-ratio basal insulin glucagon-like peptide-1 receptor agonist combinations?Kevin Cowart, Nicholas W Carris
Pageof 5